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Objectives 
The effects of acute coronary syndrome (ACS) events on healthrelated quality of life (HRQoL) and the 
time dependency of these effects are unknown. The aim of this study is to characterise health utilities in 
ACS patients. This will help development of future economic models estimating the cost per quality 
adjusted life year impact of ACS events and potential treatments.  
Methods 
Multicentre, non-interventional, longitudinal evaluation of health utility in patients experiencing ACS or 
stroke events. EuroQol-5 dimension surveys were sent to patients (≥18 years) from three centres in the 
UK 1 month following hospital admission for myocardial infarction (MI), unstable angina (UA) or stroke. 
Patient demographics, lifestyle and baseline utility score were collected in the first survey. Follow-up 
surveys were sent at 6, 12, 18 and 24 months to prospectively capture utility and subsequent health 
events. A group of patients were also identified retrospectively and patient demographics, lifestyle, and 
time since previous ACS event were collected. General healthy population utility values were assumed 
for pre-event HRQoL.  
Results  
Between January 2011 and March 2014, 2103 prospectively/retrospectively identified patients (mean 
age 68.3 [range 24–97] years; 67.9% male) responded: 1176 (55.9%) MI; 898 (42.7%) UA; 29 (1.4%) 
stroke; 24% had type 2 diabetes. Utility values post-event were lower than general healthy population 
values, although significant differences in utility among subsequent 6, 18, 12 and 24-month timepoints 
were not detected. However, a significant difference in utility between 12 and 18 months for the 
retrospectively identified subgroup only was observed. Through multivariate regressions analyses, 
wheelchair use, current smoking and secondary mental and joint health events were associated with the 
greatest utility decrements (>0.250 decrease).  
 
Conclusions:  
This study indicates that health utility decreases following a CV event and, while some improvement 
occurs over the subsequent 24 months, general healthy population utility is not necessarily attained. 
